2018 annual financial data
Nurix Therapeutics 2018 Operating cash flow margin
Direct answer
Operating cash flow margin was -84.58%.
Operating income was -9,739,000 USD and net income was -9,428,000 USD.
Operating cash flow was -31,675,000 USD.
Get free Nurix Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 37,449,000 USD
- Operating income
- -9,739,000 USD
- Net income
- -9,428,000 USD
- Operating cash flow
- -31,675,000 USD